Sökresultat - Lucie Sharpsten

  • Visas 1 - 7 av 7 resultat
Förfina resultatet
  1. 1
    One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration

    One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration av Cheryl A. Arcinue, Feiyan Ma, Giulio Barteselli, Lucie Sharpsten, Maria Laura Gomez, William R. Freeman

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Use of Statistical Analyses in the Ophthalmic Literature

    Use of Statistical Analyses in the Ophthalmic Literature av Renato Lisboa, Daniel Meira-Freitas, Andrew J. Tatham, Amir H. Marvasti, Lucie Sharpsten, Felipe A. Medeiros

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects

    The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects av Naira Khachatryan, Felipe A. Medeiros, Lucie Sharpsten, Christopher Bowd, Pamela A. Sample, Jeffrey M. Liebmann, Christopher A. Girkin, Robert N. Weinreb, Atsuya Miki, Naama Hammel, Linda M. Zangwill

    Publicerad 2015
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma Suspect Eyes

    Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma Suspect Eyes av Atsuya Miki, Felipe A. Medeiros, Robert N. Weinreb, Sonia Jain, Feng He, Lucie Sharpsten, Naira Khachatryan, Naama Hammel, Jeffrey M. Liebmann, Christopher A. Girkin, Pamela A. Sample, Linda M. Zangwill

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

    A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings av Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan, Renée Komorowski, Shanaka Stanislaus, Yuan Cheng, Bin Wu, James R. Falsey, Todd Hager, Veena A. Thomas, Malhar Ambhaikar, Lucie Sharpsten, Yineng Zhu, Vamsi Kurra, Rohini Jeswani, Rajneet K. Oberoi, Jane R. Parnes, Narimon Honarpour, Joel Neutel, Jennifer L. Strande

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: <scp>GALACTIC‐HF</scp> baseline characteristics and comparison with contemporary clinical trials

    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: <scp>GALACTIC‐HF</scp> baseline characteristics and comparison with contemporary clinical trials av John R. Teerlink, Rafael Díaz, G. Michael Felker, John J.V. McMurray, Marco Metra, Scott D. Solomon, Kirkwood F. Adams, Inder S. Anand, Alexandra Arias‐Mendoza, Tor Biering‐Sørensen, Michael Böhm, Diana Bonderman, John G.F. Cleland, Ramón Corbalán, Maria G. Crespo‐Leiro, Ulf Dahlström, Luis Eduardo Echeverría, James C. Fang, Gerasimos Filippatos, Cândida Fonseca, Eva Gonçalvesová, Assen Goudev, Jonathan G. Howlett, David E. Lanfear, Mayanna Lund, Peter S. Macdonald, Mareev VIu, Shin‐ichi Momomura, Eileen O’Meara, Alexander Parkhomenko, Piotr Ponikowski, Félix José Alvarez Ramires, Pranas Šerpytis, Karen Sliwa, Jindřich Špinar, Thomas M. Suter, János Tomcsányi, Hans Vandekerckhove, Dragoş Vinereanu, Adriaan A. Voors, Mehmet Birhan Yılmaz, Faı̈ez Zannad, Lucie Sharpsten, Jason C. Legg, Siddique Abbasi, Claire Varin, Fady I. Malik, Christopher E. Kurtz

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

    Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure av John R. Teerlink, Rafael Díaz, G. Michael Felker, John J.V. McMurray, Marco Metra, Scott D. Solomon, Kirkwood F. Adams, Inder S. Anand, Alexandra Arias‐Mendoza, Tor Biering‐Sørensen, Michael Böhm, Diana Bonderman, John G.F. Cleland, Ramón Corbalán, María G. Crespo‐Leiro, Ulf Dahlström, Luis Eduardo Echeverría, James C. Fang, Gerasimos Filippatos, Cândida Fonseca, Eva Gonçalvesová, Assen Goudev, Jonathan G. Howlett, David E. Lanfear, Jing Li, Mayanna Lund, Peter S. Macdonald, Mareev VIu, Shin‐ichi Momomura, Eileen O’Meara, Alexander Parkhomenko, Piotr Ponikowski, Félix José Alvarez Ramires, Pranas Šerpytis, Karen Sliwa, Jindřich Špinar, Thomas Suter, János Tomcsányi, Hans Vandekerckhove, Dragoş Vinereanu, Adriaan A. Voors, Mehmet Birhan Yılmaz, Faı̈ez Zannad, Lucie Sharpsten, Jason C. Legg, Claire Varin, Narimon Honarpour, Siddique Abbasi, Fady I. Malik, Christopher E. Kurtz

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: